ERONMWON OKOYE: Open Payments
NPI 1093293839 · ELIZABETH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 18 payments from 7 companies in 2025. Trend: 2023 $417 · 2024 $152 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $295 |
| E.R. Squibb & Sons, L.L.C. | 2 | $116 |
| Teva Pharmaceuticals USA, Inc. | 4 | $67 |
| ABBVIE INC. | 2 | $46 |
| Lundbeck LLC | 2 | $39 |
| Alkermes, Inc. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: REXULTI, ABILIFY ASIMTUFII, COBENFY, UZEDY, ABILIFY MAINTENA, VRAYLAR, ARISTADA, INVEGA SUSTENNA.
Industry payments across NJ — which companies pay providers there.
